We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$910M
AUM Growth
+$303M
(+50%)
Cap. Flow
+$298M
Cap. Flow
% of AUM
32.79%
Top 10 Holdings %
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXGXU
GX Acquisiton Corp. Unit
GXGXU
|
+$2.63M |
| 2 |
LCAHU
Landcadia Holdings II, Inc. Unit
LCAHU
|
+$2.3M |
| 3 |
HYACU
Haymaker Acquisition Corp. II Unit
HYACU
|
+$1.62M |
| 4 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.35M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.76% |
| 2 | Consumer Discretionary | 1.21% |
| 3 | Technology | 1% |
| 4 | Financials | 0.87% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
CALL
Cleveland-Cliffs
CLF
$6.81B
| $305K | 0.03% |
28,600
-27,300
| -49% | -$269K |
|
|
BRSL
727
PUT
Brightstar Lottery PLC
BRSL
$1.91B
| $305K | 0.03% |
23,500
+6,900
| +42% | +$93.8K |
|
|
CCX.U
728
DELISTED
Churchill Capital Corp II
CCX.U
| $305K | 0.03% |
+30,000
| New | +$304K |
|
729
CALL
Aramark
ARMK
$15B
| $303K | 0.03% |
+11,634
| New | +$272K |
|
|
DVAX
730
DELISTED
Dynavax Technologies
DVAX
| $303K | 0.03% |
+76,000
| New | +$441K |
|
731
CALL
G-III Apparel Group
GIII
$1.47B
| $303K | 0.03% |
10,300
+9,200
| +836% | +$314K |
|
|
GRMN
732
PUT
Garmin
GRMN
$46.9B
| $303K | 0.03% |
3,800
+1,500
| +65% | +$123K |
|
733
ANI Pharmaceuticals
ANIP
$1.77B
| $301K | 0.03% |
3,656
+3,036
| +490% | +$216K |
|
734
CALL
Walt Disney
DIS
$165B
| $300K | 0.03% |
2,145
-1,383
| -39% | -$183K |
|
|
VNET
735
VNET Group
VNET
$2.05B
| $299K | 0.03% |
+38,322
| New | +$293K |
|
|
ARNA
736
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $299K | 0.03% |
5,100
-4,800
| -48% | -$248K |
|
|
LM
737
PUT
DELISTED
Legg Mason, Inc.
LM
| $299K | 0.03% |
+7,800
| New | +$270K |
|
738
PUT
Tenet Healthcare
THC
$20.1B
| $298K | 0.03% |
+14,400
| New | +$332K |
|
739
PUT
Artisan Partners
APAM
$2.79B
| $297K | 0.03% |
+10,800
| New | +$288K |
|
740
CALL
TFS Financial
TFSL
$5.1B
| $296K | 0.03% |
+16,400
| New | +$280K |
|
|
AERI
741
DELISTED
Aerie Pharmaceuticals
AERI
| $296K | 0.03% |
+10,003
| New | +$385K |
|
742
PUT
Jack Henry & Associates
JKHY
$10.7B
| $295K | 0.03% |
+2,200
| New | +$304K |
|
|
CVSA
743
Covista Inc
CVSA
$3.94B
| $294K | 0.03% |
+6,536
| New | +$300K |
|
|
VISN
744
CALL
Vistance Networks Inc
VISN
$2.66B
| $293K | 0.03% |
+18,600
| New | +$378K |
|
745
CALL
Criteo
CRTO
$1.03B
| $293K | 0.03% |
+17,000
| New | +$334K |
|
746
CALL
AtriCure
ATRC
$1.77B
| $292K | 0.03% |
+9,800
| New | +$286K |
|
747
CALL
Humana
HUM
$46.7B
| $292K | 0.03% |
1,100
+300
| +38% | +$76.1K |
|
|
YELL
748
DELISTED
Yellow Corporation Common Stock
YELL
| $292K | 0.03% |
72,597
+70,797
| +3,933% | +$410K |
|
749
CALL
NovoCure
NVCR
$2.04B
| $291K | 0.03% |
4,600
-14,400
| -76% | -$730K |
|
750
Dell
DELL
$283B
| $290K | 0.03% |
11,246
+7,616
| +210% | +$238K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.
- Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
- Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
- Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
- Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
- Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
- Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
- Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.
Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.